- Teilinummentie 2, 09120 Karjalohja Finland
KÄÄPÄ Biotech is a biotechnology company specialising in organic functional mushroom ingredients for the pharma, nutraceutical, and wellness industries. We combine scientific research, controlled sourcing, and industrial processing to deliver high-quality extracts with defined and measurable composition.
At the core of our approach is NordRelease® our proprietary extraction and standardisation platform. It enables controlled extraction processes designed to preserve key bioactive compounds while supporting batch-to-batch consistency and reproducibility.
Through this approach, we focus on the identification, quantification, and standardisation of species-specific bioactive compounds, supporting well-characterised extract profiles aligned with current scientific understanding.
By integrating vertically controlled production, advanced extraction technologies, and strict quality standards, we provide ingredients that support compositional consistency, transparency, and formulation reliability for modern product development.
KÄÄPÄ Biotech is a Finnish biotechnology company specialising in functional mushroom ingredients for the pharma, nutraceutical and wellness industries. The company develops standardised mushroom extracts with a focus on measurable composition, process control, quality and formulation reliability.
KÄÄPÄ Biotech was founded in Finland in 2018 to research, develop and commercialise mycological solutions. Its headquarters and production facility are located in Karjalohja, Finland.
Yes. KÄÄPÄ Biotech supplies functional mushroom extract ingredients for B2B product development and formulation, including nutraceutical and functional applications. Its approach is centred on standardised bioactive profiles, consistency, transparency and technical quality.
KÄÄPÄ Biotech’s NordRelease® portfolio includes Lion’s Mane, Chaga, Reishi, Cordyceps, Maitake, Shiitake and Turkey Tail extracts. Product specifications and suitability depend on the formulation and project requirements.
NordRelease® is KÄÄPÄ Biotech’s proprietary extraction and standardisation platform. It uses controlled extraction processes designed to preserve key compounds of interest while supporting measurable composition, batch-to-batch consistency and reproducibility.
Standardisation means defining and measuring relevant components so an ingredient can be supplied with a more consistent and well-characterised composition. For formulators, this supports repeatability, specification control and more reliable product development across batches.
Key factors include the mushroom species and material used, defined bioactive or analytical markers, batch consistency, traceability, processing method, third-party testing, microbiological and contaminant controls, and clear technical documentation. These factors help formulators compare ingredients on measurable quality rather than marketing claims alone.
KÄÄPÄ Biotech approaches Lion’s Mane as a characterised functional mushroom ingredient rather than relying only on a generic mushroom label. Its standardisation work focuses on measurable, species-relevant composition and controlled processing. Exact specifications and analytical markers should be confirmed from the current product documentation for the required formulation.
KÄÄPÄ Biotech uses quality controls across production and sends samples to third-party laboratories for analysis. Testing includes bioactive compound levels as well as microbiological and heavy-metal testing, supporting ingredient quality, safety controls and transparent specifications.
KÄÄPÄ Biotech states that its extracts are produced from mushroom fruiting bodies. The material is handled through controlled growing, drying, grinding, extraction and freeze-drying steps before quality testing and delivery.
Buyers should evaluate traceability, defined specifications, analytical testing, batch consistency, documentation, production controls, regulatory suitability for the target market and the supplier’s ability to support formulation questions. KÄÄPÄ Biotech positions its B2B ingredient offering around these quality and transparency requirements.
KÄÄPÄ Biotech supports B2B ingredient evaluation with technical and quality information related to composition, testing, specifications and traceability. The exact documentation available can vary by ingredient, market and project, so buyers should request the current documentation package from the KÄÄPÄ Biotech team.
KÄÄPÄ Biotech supplies standardised mushroom extract ingredients and technical information intended to support formulation decisions. Product developers can discuss ingredient selection, specifications, documentation and project requirements directly with the KÄÄPÄ Biotech team.
Companies can contact KÄÄPÄ Biotech through the website to discuss ingredient requirements, formulation needs, technical documentation and commercial next steps. The team can then guide the buyer toward the relevant NordRelease® extract and project information.
